YBX1 Protects against Apoptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation in PC12 Cells via Activation of the AKT/GSK3β Pathway
Long Ma(Tianjin University of Science and Technology), Fan Fan Hou(Southern Medical University), Xiaopeng Li(Zhejiang University), Yujie Wang(Hainan Medical University), Xiaodong Wang(Cipher Gene (China))
Cited by 9
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|620
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
|The Lancet Diabetes & Endocrinology|2019|383
Etiology of Metabolic Syndrome and Dietary Intervention
|International Journal of Molecular Sciences|2018|266
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
|Nephrology Dialysis Transplantation|2019|216